<DOC>
	<DOCNO>NCT02492438</DOCNO>
	<brief_summary>To assess immunogenicity PCV13 ( 13 valent pneumococcal conjugate vaccine ) vaccine compare PPV23 ( 23 valent pneumococcal polysaccharide vaccine ) vaccine patient treat chronic hemodialysis pre-immunized PPSV23 vaccine PPV23 vaccine naïve measure ELISA OPA ( opsonophagocytic assay ) titers 4 52 week .</brief_summary>
	<brief_title>13 Valent Pneumococcal Conjugate Vaccine Chronic Dialysis Patients</brief_title>
	<detailed_description>The immunogenicity PCV13 ( 13 valent pneumococcal conjugate vaccine ) vaccine compare PPV23 ( 23 valent pneumococcal polysaccharide vaccine ) vaccine patient treat chronic hemodialysis pre-immunized PPV23 vaccine PPV23 vaccine naïve measure ELISA OPA ( opsonophagocytic assay ) titers 4 52 week .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>1. chronic dialysis treatment 2. 50 year old pregnant 3. immediate life threaten condition 4. allergic one compound vaccine 5. known pneumococcal vaccination status 6. give inform consent . Patients fulfil inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>pneumococcal vaccination</keyword>
	<keyword>dialysis</keyword>
	<keyword>immune response</keyword>
</DOC>